Reviewed profile

food and beverage brand · public preview

ZAPOPHARMA

Retail brand

Public category
Retail brand
Brand tier
mainstream brand
Headquarters
France
Is this your company?Claim ZAPOPHARMA to get found by buyers, add products and certifications, correct your details, and be eligible when Talio’s AI recommends suppliers.Let our AI make the introductionGet a warm, researched intro to ZAPOPHARMA — no cold outreach.
Report a changeLog in for full recordLast reviewed 28 Mar 2026 · public preview data

Overview

What ZAPOPHARMA covers.

AdipoPharma is a French biotechnology company focused on the development of novel therapeutic peptides for the treatment of type 2 diabetes and metabolic disorders. Its lead candidate, PATAS, is a first-in-class insulin sensitizer designed to restore adipocyte function and address insulin resistance at its root cause. The company was founded based on research into the role of adipocytes in metabolic regulation and lipid homeostasis.

  • Positioned as a mainstream brand.
  • Headquartered in France.

FAQ

Questions this page answers.

What does ZAPOPHARMA do?

ZAPOPHARMA is a food and beverage brand based in France, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, correct outdated details, and stay eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Claim this pageLog in for full recordReport a change

Public preview data only · proprietary metrics remain in authenticated Talio.